Barclay A. Phillips

CIK: 0001265801

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMUX

IMMUNIC, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

IMUX
IMMUNIC, INC.
Jul 5, 2026
Award(A)
Stock Option
Direct
25.4K shares-
IMUX
IMMUNIC, INC.
Jun 29, 2026
Award(A)
Stock Option
Direct
25.4K shares-
IMUX
IMMUNIC, INC.
Jun 5, 2025
Award(A)
Stock Option
Direct
150K shares-

		Type	Shares	Price		Ownership
Jul 5, 2026	IMUX IMMUNIC, INC.	Award(A) Stock Option	25,370	-	-	Direct
Jun 29, 2026	IMUX IMMUNIC, INC.	Award(A) Stock Option	25,370	-	-	Direct
Jun 5, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Option	150,000	-	-	Direct

1-3 of 3 transactions

About PHILLIPS BARCLAY A

PHILLIPS BARCLAY A (SEC CIK 0001265801) files insider reports with the SEC as Director of IMMUNIC, INC. (IMUX).

Signal8 holds 3 ownership filings by PHILLIPS BARCLAY A, all Form 4s, filed between Jun 9, 2025 and Jul 7, 2026. Those filings report 3 transactions, from Jun 5, 2025 to Jul 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PHILLIPS BARCLAY A's filings is in NEW YORK, NY.

Recent filings by PHILLIPS BARCLAY A

Jul 5, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
Jun 29, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of IMUX derivative securities (Form 4, code A).

Other insiders filing for IMMUNIC, INC. (IMUX)

How to read Form 4 transaction codes